Informations générales (source: ClinicalTrials.gov)
                                    Improvement of Live Babies Rates After ICSI, Using cpFT: Multicenter Prospective Randomized Clinical Trial
                                
                            
                                    Interventional
                                
                            
                                    Phase 3
                                
                            
                                    Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
                                
                            
                                    juillet 2021
                                
                            
                                    juillet 2026
                                
                            
                                    17 septembre 2025
                                
                            
                                    Demonstrate the improvement of the live births rate after ICSI by supplementing the
pre-ICSI incubation medium of oocytes and that of preimplantation embryos with cpFT at
the 1st embryo transfer for women under 37 years old.
                                
                            Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CH DES QUATRE VILLES SITE ST CLOUD | WOLF Jean-philippe | 01/11/2025 08:14:42 | Contacter | ||
| CLINIQUE DE LA MUETTE | WOLF Jean-philippe | 01/11/2025 08:14:42 | Contacter | ||
| HOPITAL DE LA CROIX SAINT SIMON | WOLF Jean-philippe | 01/11/2025 08:14:42 | Contacter | ||
| HOPITAL PIERRE ROUQUES LES BLUETS | WOLF Jean-philippe | 01/11/2025 08:14:41 | Contacter | ||
| AP-HP Assistance publique - Hôpitaux de Paris | 01/11/2025 08:14:42 | Contacter | |||
| AP-HP - Hôpital Bichat | |||||
| AP-HP - Hôpital Cochin | |||||
| AP-HP - Hôpital Jean Verdier | |||||
Critères
                                    Femme
                                
                            
                                    Inclusion Criteria:
- Couples eligible for a first attempt at Assisted Reproduction (AMP).
- Couples asking for Assisted Reproductive Technology, and requiring an ICS procedure.
- Women aged 18 to 36 inclusive.
- Men aged 18 to 58 inclusive
- Use of CSCM-C culture medium from Biocare / Irvine, exclusively.
- People affiliated to a Social Security scheme
                                
                            - Couples eligible for a first attempt at Assisted Reproduction (AMP).
- Couples asking for Assisted Reproductive Technology, and requiring an ICS procedure.
- Women aged 18 to 36 inclusive.
- Men aged 18 to 58 inclusive
- Use of CSCM-C culture medium from Biocare / Irvine, exclusively.
- People affiliated to a Social Security scheme
- Lack of consent
- Early menopause.
- Couples under IVF or Intra Uterine Insemination treatment.
- People unable to follow protocol visits in France.
- Couple with a contraindication to treatment with ART.
- Women with a contraindication to treatment with ART or an associated pathology such
as: hypertension, risk of eclampsia, family genetic problems, diabetes, uterine
partitions, synechiae adhesions, adenomyosis or any other contraindication judged as
such by the investigator.
- ART with donation of gametes or embryos.
- Participant under guardianship or guardianship